Stock screener

RCUS

Conviction 83HealthcareScan · Mon, Aug 10, 2026
RCUS$28.70+0.28%
ResistanceSupportVol 14Insider sell
63 bars
2
2
Vol MA14 1.22M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Arcus Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.arcusbio.com
Price28.70
Change+0.28%
Gap+0.17%
Rel volume1.19×
Avg volume1.15M
Avg $ vol32.32M
SMA 2028.18
SMA 5027.35
SMA 20023.62
Price vs 50+4.95%
Price vs 200+21.49%
MA stackbullish
50/200 cross
Supertrendup · 26.42
RSI (14)53
MACD hist-0.03
MACD cross
Stoch %K / %D51 / 48
ADX (14)12
+DI / −DI18 / 18
RSI divergence
MACD divergenceBullish
ATR %+5.14%
ADR %4.87%
52w high31.08
52w low9.06
From 52w high-7.66%
Above 52w low+216.78%
New 52w highNo
SqueezeOn · 4d
Bollinger width12.79%
%B0.64
Donchian pos55.82%
Donchian high31.09
Donchian low25.68
AVWAP (52w high)28.74
vs AVWAP high-0.12%
AVWAP (52w low)21.99
vs AVWAP low+30.50%
OBV trendFlat
Chaikin MF (20)-0.08
Today vs 20d1.19×
Avg vol (14d)1.22M
Avg vol (20d)1.15M
Avg $ vol (20d)32.32M
Market cap
RS 3m (vs SPY)+9.80%
RS 6m (vs SPY)+28.77%
RS line new highNo
Trend template8/8
Technical rank79.0
1 week+3.91%
1 month-0.76%
3 months+13.17%
6 months+36.47%
1 year+209.27%
YTD+23.23%
P/E-10.35
P/B7.88
P/S110.74
P/FCF-7.55
EPS-3.29
Div yield
ROE-76.08%
ROA-38.20%
Debt/Eq0.22
Current3.82
EV/EBITDA
Gross margin
Net margin
Rev growth-35.29%
EPS growth-24.73%
Price target38.33
Target upside33.55%
Analyst ratingBuy
Institutional101.38%
Ent. value3.61B
Revenue33M
Net income-91M
Gross profit
Free cash flow-484M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out125.77M
Employees601
ListedThu, Mar 15, 2018
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeA
Conviction83 / 100
Pattern quality
Tech rank79.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance31.59
Support25.94
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RCUS

All disclosures →
No recent disclosed trades by Congress in RCUS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RCUS · 3 buys · 7 sells

InsiderSideShares
Jaen Juan C.
President · Common Stock · 2026-07-10
Sell19.8K
Jaen Juan C.
President · Common Stock · 2026-07-10
Sell268
Jaen Juan C.
President · Common Stock · 2026-07-09
Sell48.5K
Jaen Juan C.
President · Common Stock · 2026-06-24
Sell6.43K
Jaen Juan C.
President · Common Stock · 2026-06-23
Sell1.7K
Jaen Juan C.
President · Common Stock · 2026-06-23
Sell14.07K
Jaen Juan C.
President · Common Stock · 2026-06-22
Sell9.24K
Machado Patrick
Director · Stock Option (Right to Buy) · 2026-06-11
Grant16.9K
Lacey David L.
Director · Common Stock · 2026-06-11
Grant5.7K
Lacey David L.
Director · Stock Option (Right to Buy) · 2026-06-11
Grant16.9K

SEC filings

EDGAR filings in RCUS · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.